Genmab reported DKK24.91B in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Agios Pharmaceuticals AGIO:US $ 1335.86M 101.88M
Amarin AMRN:US $ 973.71M 94.36M
Amgen AMGN:US $ 59196M 1969M
Artemis Alpha ATS:LN 164.51M 22.2M
AstraZeneca AZN:LN 100273M 5090M
Bayer BAYN:GR € 125782M 5541M
Biomarin Pharmaceutical BMRN:US $ 6062.71M 59.38M
Bluebird Bio BLUE:US $ 491.07M 102.72M
Exelixis EXEL:US $ 2654.12M 37.88M
Fresenius Medical Care FME:GR € 34724.13M 357.57M
Galapagos GLPG:NA € 5100.31M 92.84M
Genmab GEN:DC DK 24914M 287M
GlaxoSmithKline GSK:LN 89689M 10586M
GN Store Nord GN:DC DK 27519M 3967M
GRIFOLS GRF:SM € 16213.05M 75.45M
H. Lundbeck A/S LUN:DC 35.07B 418M
Hikma Pharmaceutical HIK:LN 4.37B 192M
Immunogen IMGN:US $ 481.71M 44.06M
Insmed INSM:US $ 1.15B 90.19M
Lonza Group LONN:SW 16.46B 1.3B
Merck MRK:GR € 46235M 873M
Novartis NOVN:VX SF 125218M 6577M
Regeneron Pharmaceuticals REGN:US $ 26348.7M 913.9M
Seattle Genetics SGEN:US $ 3616.69M 102.91M
William Demant Holding WDH:DC 24.86B 1.28B